hVIVO (LSE:HVO) Total Long-Term Liabilities: £15.92 Mil (As of Dec. 2025)


What is hVIVO Total Long-Term Liabilities?

hVIVO LSE:HVO -2.00% Total Long-Term Liabilities is £15.92 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. hVIVO's Total Long-Term Liabilities for the quarter that ended in Dec. 2025 was £15.92 Mil.

hVIVO Total Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for hVIVO's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

hVIVO Total Long-Term Liabilities Chart

hVIVO Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 1.40 13.72 12.30 15.92

hVIVO Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.72 13.27 12.30 15.49 15.92

hVIVO Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

What does a Total Long-Term Liabilities of £15.92 Mil mean?
hVIVO (LSE:HVO) has a Total Long-Term Liabilities of £15.92 Mil as of Dec. 2025. Toal Long-Term Liabilities is the obiligation expected to be repaid beyond the following twelve months or one business cycle. View historical data on hVIVO and its competitors.
Is hVIVO's Total Long-Term Liabilities too high?
hVIVO's current Total Long-Term Liabilities is £15.92 Mil.
How does hVIVO's Total Long-Term Liabilities compare to TMO and DHR?
hVIVO's Total Long-Term Liabilities of £15.92 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Liabilities for a Medical Diagnostics & Research company?
A good Total Long-Term Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Liabilities mean?
A high Total Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Toal Long-Term Liabilities is the obiligation expected to be repaid beyond the following twelve months or one business cycle. View historical data on hVIVO and its competitors. hVIVO's current Total Long-Term Liabilities is £15.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is hVIVO stock overvalued right now?
Based on GuruFocus' analysis, hVIVO (LSE:HVO) is currently considered Possible Value Trap. The stock's GF Value™ is £0.16, compared to a current price of £0.07 — trading 54.1% below its estimated fair value. The current Total Long-Term Liabilities is £15.92 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Liabilities calculated?
Total Long-Term Liabilities is calculated from a company's financial statements. For hVIVO (LSE:HVO), the current Total Long-Term Liabilities is £15.92 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

hVIVO Business Description

Other Exchanges OPORF:USACRO:Germany
Address 40 Bank Street, Floor 24, London, GBR, E14 5NR
hVIVO PLC is a full-service early phase Contract Research Organisation (CRO). It delivers end-to-end clinical development services to a diverse and expanding client base. The group specialises in conducting human challenge trials across multiple infectious and respiratory indications. It also offers comprehensive virology and immunology laboratory services under the hLAB brand. Through its subsidiary, it provides early-phase clinical trial services and Early Drug Development Consulting and Biometry services to the biopharma sector. It provides development solutions from preclinical stages through Phase II trials, via FluCamp. Geographically, the company generates maximum revenue from Europe, followed by North America, the United Kingdom, and Asia.